New drug could quiet 'Ticking time Bomb' plaques in the neck
NCT ID NCT07586540
First seen May 15, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests whether adding the drug alirocumab to standard statin therapy can shrink dangerous bleeding spots inside fatty plaques in the carotid artery. About 280 people who recently had a mini-stroke or stroke due to a 50-69% blocked neck artery will receive injections every two weeks for 26 weeks. The goal is to see if the drug makes these plaques less likely to cause future strokes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAROTID STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aga Khan University
Karachi, Pakistan
-
Ain Shams University
Cairo, Egypt
-
Alexandria University, Smouha University Comprehensive Stroke Center
Alexandria, Egypt
-
Amman Specialized IR Center
Amman, Jordan
-
Cairo University
Cairo, Egypt
-
Centre Hospitalier Universitaire Ibn Sina de Rabat
Rabat, Morocco
-
Department of Neurology, Eskisehir Osmangazi University
Eskişehir, Turkey (Türkiye)
-
Institut National de Neurologie
Tunis, Tunisia
-
King Abdulaziz Medical City
Jeddah, Saudi Arabia
-
King Abdullah Medical City
Mecca, Saudi Arabia
-
King Khalid University
Abhā, Saudi Arabia
-
Neurology Department, Al-Azhar University
Cairo, Egypt
-
Neurology Department, Dr. Lutfi Kirdar City Hospital
Istanbul, Turkey (Türkiye)
-
Weill Cornell Medicine-Qatar
Doha, Qatar
Conditions
Explore the condition pages connected to this study.